EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Slow and extended release products Mechanisms of release and possibilities of control



Slow and extended release products Mechanisms of release and possibilities of control



Blume, H , Gundert-Remy, U , Moeller, H Paperback APV; Controlled/modified release products: Recommendation in support of EC-guidelines : 15-33




(PDF emailed within 1 workday: $29.90)

Accession: 033411989

Download citation: RISBibTeXText



Related references

Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets. Therapeutic Delivery 7(8): 553-572, 2016

Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine: cross-over study. Journal of Cardiovascular Pharmacology 26(6): 974-977, 1995

Comparison of clinical efficacy and adverse effects between extended-release felodipine and slow-release diltiazem in patients with isolated systolic hypertension. Changgeng Yi Xue Za Zhi 22(1): 44-51, 1999

Influence of some factors on the in vitro release velocity of active materials from slow release tablets part 3 release velocity of tetracycline hydro chloride from stored and nonstored slow release tablets. Die Pharmazie 33(4): 212-216, 1978

In vitro and in vivo ammonia release studies on various slow-release urea products. 1974

Effects of temperature on nutrient release from slow-release fertilizers. I. Commercial and experimental products. Nutrient Cycling in Agroecosystems 46(3): 179-187, 1997

Nitrogen release dynamics and transformation of slow release fertiliser products and their effects on tea yield and quality. Journal of the Science of Food and Agriculture 88(5): 839-846, 2008

Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial. Journal of the American Society of Hypertension 3(3): 210-220, 2010

Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain. Current Medical Research and Opinion 30(6): 1139-1151, 2015

Bioavailability of 3 formulations of pseudo-ephedrine EFIDAC/24, a 24h-slow-release tablet, in comparison with sudafed, an immediate-release tablet, and NASA-12, A 12h-slow-release capsule. Therapie (Paris) 0(SUPPL ): 488, 1995

Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. International Journal of Clinical Pharmacology and Therapeutics 45(12): 662-668, 2008

Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study. European Journal of Clinical Pharmacology 53(2): 95-100, 1997

Conversion from immediate-release to extended-release lamotrigine improves seizure control. Epilepsy Research 108(9): 1637-1641, 2015

Evaluation of the release rate of an enveloped slow-release larvicide and its efficacy in mosquito control. Zhonghua Liu Xing Bing Xue Za Zhi 6(3): 153-155, 1985

Physiologically Based Pharmacokinetic Modeling for Substitutability Analysis of Venlafaxine Hydrochloride Extended-Release Formulations Using Different Release Mechanisms: Osmotic Pump Versus Openable Matrix. Journal of Pharmaceutical Sciences 105(10): 3088-3096, 2016